Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Erlotinib","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=erlotinib","facts":[{"label":"Active ingredient \/ generic name","value":"erlotinib"}]},{"title":"Klacid MR 500 mg (Turkish record)","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=klacid-mr-500-mg","facts":[{"label":"Active ingredient \/ generic name","value":"Klaritromisin"},{"label":"ATC code","value":"J01FA09"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"DailyMed erlotinib (Camber) SPL v1, effective 2024-06-26; checked 2026-11-04; 7 and 12.3"}],"sources":[{"label":"Erlotinib tablets (Camber) \u2014 US prescribing information","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a3b2d622-b4d5-4819-862b-f8fd3adcec6f"},{"label":"FDA: clinical examples of drugs interacting with CYP enzymes and transporter systems","url":"https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:35520","available":true}}